Toggle light / dark theme

Unexpected finding could offer new treatment targets for meth addiction

University of Florida neuroscientists have made a mechanistic discovery that paves the way to test immune-modulating medicines as a potential tool to break the cycle of methamphetamine addiction.

In a new preclinical study, a McKnight Brain Institute team led by Habibeh Khoshbouei, Ph.D., Pharm. D., examined the role of neuroinflammation in meth addiction to provide a deeper understanding of the mechanisms at work.

“Unlike alcohol or opioids, there currently is no medicinal therapeutic approach for methamphetamine addiction,” said Khoshbouei, a professor of neuroscience and psychiatry. “So this is an important societal issue.”

Scientists report new immune insights and targets into LRRK2 mutations in Parkinson’s disease

Parkinson’s disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra, a brain region essential for motor control. Clinically, it is marked by tremor, rigidity, bradykinesia and postural instability, symptoms that progressively erode independence and quality of life.

PD affects millions of people worldwide, including nearly one million individuals in the United States, making it one of the fastest-growing neurological disorders. In the U.S. alone, the disease imposes a profound health care and socioeconomic burden, with annual costs reaching tens of billions of dollars due to medical care, lost productivity and long-term disability.

While environmental factors contribute to disease risk, genetic drivers are increasingly recognized, with mutations in the leucine-rich repeat kinase 2 (LRRK2) gene representing one of the most common causes of both familial and sporadic PD. Understanding how LRRK2 mutations drive disease is therefore central to developing therapies that go beyond symptoms control.

How brain waves shape our sense of self

A new study from Karolinska Institutet, published in Nature Communications, reveals how rhythmic brain waves known as alpha oscillations help us distinguish between our own body and the external world. The findings offer new insights into how the brain integrates sensory signals to create a coherent sense of bodily self.

What makes you feel that your hand is yours? It might seem obvious, but the brain’s ability to tell self from non-self is a complex process.

Using a combination of behavioral experiments, brain recordings (EEG), brain stimulation, and computational modeling with a total of 106 participants, researchers from Karolinska Institutet investigated how the brain combines visual and tactile signals to create the feeling that a body part belongs to oneself—a phenomenon known as the sense of body ownership.

Association Between Circadian Rest-Activity Rhythms and Incident Dementia in Older AdultsThe Atherosclerosis Risk in Communities Study

Weaker and more fragmented circadian rest-activity rhythms and later peak activity time were associated with elevated dementia risk in this study.

First Therapy Chatbot Trial Yields Mental Health Benefits

face_with_colon_three Year 2025


Dartmouth researchers conducted the first-ever clinical trial of a generative AI-powered therapy chatbot and found that the software resulted in significant improvements in participants’ symptoms, according to results published March 27 in NEJM AI.

People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental health professional.

The trial consisted of 106 people from across the United States diagnosed with major depressive disorder, generalized anxiety disorder, or an eating disorder. Participants interacted with Therabot through a smartphone app by typing out responses to prompts about how they were feeling or initiating conversations when they needed to talk.

New Israeli study may unlock key clues to autism and brain development

A study being conducted at The Hebrew University of Jerusalem, led by Professor Sagiv Shifman, found that many genes are essential for healthy brain cell development, but only a small share are currently connected to recognized neurodevelopmental disorders.

Read more from ynet here.


The researchers also identified clear patterns in how different genes contribute to disease. Genes that regulate other genes, such as transcription and chromatin regulators, were more often linked to dominant disorders, where a mutation in a single copy of a gene can cause illness. In contrast, genes involved in metabolic processes were typically associated with recessive disorders, requiring mutations in both copies of the gene.

To validate their findings, the team studied eight genes in mouse models — including PEDS1, EML1 and SGMS1 — and found major abnormalities in brain structure. In four of the cases, the mice developed microcephaly, a condition marked by an abnormally small brain.

One gene, PEDS1, emerged as particularly significant. The gene plays a key role in producing plasmalogens, a class of lipids essential to cell membranes and nerve tissue. When PEDS1 was disabled in mice, brain cells exited the cell cycle too early and failed to properly differentiate and migrate, severely impairing brain development.

Naturally occurring molecule shown to restore memory function in Alzheimer’s models

Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health toward the end of life. Scientists from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working to understand how aging itself can be modified to prevent age-related diseases, including Alzheimer’s disease.

A new study led by Professor Brian K Kennedy, Department of Biochemistry, Chair of the Healthy Longevity Translational Research Program (TRP), NUS Medicine, has discovered that calcium alpha-ketoglutarate (CaAKG), a safe, naturally occurring metabolite commonly studied for healthy aging, can restore key memory-related brain functions that have been disrupted in Alzheimer’s disease.

The paper is published in the journal Aging Cell.

Successful 40-Hz auditory stimulation in aged monkeys suggests potential for noninvasive Alzheimer’s therapy

A research team from the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has demonstrated for the first time in non-human primates that auditory stimulation at 40 Hz significantly elevates β-amyloid levels in the cerebrospinal fluid (CSF) of aged rhesus monkeys, with this effect persisting for over five weeks.

The study, published in the Proceedings of the National Academy of Sciences on January 5, provides the first non-human primate experimental evidence supporting the use of 40-Hz stimulation as a noninvasive physical therapy for Alzheimer’s disease (AD), revealing significant differences between primate and rodent models.

/* */